16–30 March 2023, Online
3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023)

Dear Researchers,

We are pleased to announce the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023). The conference is organized by the MDPI open-access journal Cancers ( IF 6.575) and will be held online from 16–30 March 2023.

Time Schedule
Abstract Submission Deadline: 5th January 2023
Notification of Acceptance Deadline: 31st January 2023
Full Paper Submission Deadline: 13th February 2023
Conference Open: 16–30 March 2023

Opportunities for new therapeutic targets have expanded tremendously. In recent years, cancer genomics has expanded our view of cancer vulnerabilities, new technologies have changed the paradigm of what can be successfully targeted, and new immunotherapy targets continue to emerge at a rapid pace. This conference aims to promote and advance the coordinated progress in oncology research to foster the development of innovative therapeutic strategies. It will bring together experts in basic, translational, and clinical research to discuss the current research and opportunities as well as the obstacles that lie ahead in the field.

The focus of this conference is the translation of recent discoveries into new therapeutic targets for cancer therapies. Topics of interest include but are not limited to the following:

  • Translational cancer genomics and epigenomics;
  • Emerging immunotherapy targets;
  • Overcoming therapeutic hurdles in resistance and undruggable proteins.

There will be five specific sessions:

Session 1: Genome-Wide Approaches for Target Identification;
Session 2: Targeting Metastasis;
Session 3: Novel Immunotherapy Targets;
Session 4: Novel Approaches for ‘Undruggable’ Targets;
Session 5: Overcoming Therapeutic Resistance.

Participants will have the opportunity to examine, explore, and critically engage with issues and advances in these areas. We hope to facilitate discussions and exchange within the community.

This event will be a solely online proceeding, which allows for participation from around the world with no concerns regarding travel and related expenditures. This type of conference is particularly appropriate and useful, as cancer-related research is progressing rapidly. An electronic conference provides a platform for rapid and direct exchanges about the latest research findings and novel ideas. Attendance and participation in this online conference is completely free.

The accepted conference proceedings papers and presentations will be available online for discussion on 16–30 March 2023 and will be published in the journal Medical Sciences Forum. All participants are encouraged to submit an extended full manuscript to the Cancers conference Special Issue "IECC2023: New Targets for Cancer Therapies" with a 20% discount on the APC. Cancers (ISSN 2072-6694; IF 6.575) is a peer-reviewed and open access journal of oncology that is published semimonthly online by MDPI.

We hope that the community will share our enthusiasm and help to make this conference a success.

Kind regards,
Dr. Carlos S. Moreno
The Chair of the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies

Back to TopTop